Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA284593-03
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
National Institutes of Health
Grant: 5P50CA107399-05
Career Development Program
Keywords